Health experts on Monday began a probe of how the WHO responded to the H1N1 (swine flu) pandemic “nearly a year after global alarm was raised over the new swine flu strain,” Agence France-Presse reports (Capella, 4/12).
Pneumonia & Flu
Although H1N1 (swine flu) “has waned across much of the United States, the southeast is reporting an increase in cases of the H1N1 virus, U.S. health officials said on Monday,” Reuters reports. During a conference call with reporters, Anne Schuchat of the CDC reported an uptick in the number of H1N1 cases reported in Alabama, South Carolina and Georgia (Allen, 3/29).
Also In Global Health News: H1N1; USAID’s Global Pulse; Rotavirus Vaccine; Uzbek Doctors; Zimbabwe Development; Malaria Vaccine
Independent Committee Formed To Evaluate WHO’s Response To H1N1; Cuba To Offer H1N1 Vaccine To 1.1 M WHO flu chief Keiji Fukuda on Monday announced that a group of 29 independent scientists and public health experts has been formed to evaluate the response of the organization and national governments to…
Also In Global Health News: Bird Flu; Burundi’s Global Fund Grant; Maternal Mortality In Ghana; Food Security In Africa; Messaging Strategy Of Charities
WHO Warns Bird Flu Continues To Pose Threat Despite a reduction in the number of cases of avian flu (H5N1) since its peak in 2006, the WHO said in a statement Wednesday that “the newly confirmed human and poultry cases of avian influenza this year are a reminder that the…
GlaxoSmithKline, Pfizer Will Supply 600M Doses Of Reduced-Price Pneumococcal Vaccines To Developing Countries Over 10 Years, GAVI Says
The GAVI Alliance on Tuesday formally announced that drugmakers GlaxoSmithKline and Pfizer had signed off on a “10-year deal â€¦ to supply 60 million doses a year of cut-price pneumococcal vaccines to developing nations,” Reuters reports. The agreement is under what’s “called an Advance Market Commitment (AMC) which guarantees a market for vaccines supplied to poor nations but sets a maximum price drugmakers can expect to receive,” the news service writes (Kelland, 3/23).
The WHO on Friday announced “it had delivered the first doses of H1N1 [swine flu] vaccine to Cuba, and a dozen countries in Africa would receive millions of doses in coming weeks,” Reuters reports. According to WHO spokeswoman Karen Mah, Cuba received an estimated 1.1 million doses Wednesday, and Honduras and El Salvador shipments are “en route,” according to the news service.
Opinions: Discrimination Against Sexual Orientation; WFP In Somalia; Haiti’s Recovery; WHO’s Policy Role
Discrimination Against Sexual Orientation Are ‘Backward Steps’ For Human Rights In Africa In a Washington Post opinion piece, Desmond Tutu, archbishop emeritus of Cape Town, South Africa,Â and Nobel Peace Prize recipient,Â speaks out against efforts to deny individuals “their fundamental rights and freedoms” based on their sexual orientation. Tutu citesÂ cases in…
Study Finds Pfizer’s Pneumonia, Meningitis Vaccine Protects Against Recurrent Pneumonia In HIV Patients
Pfizer’s Prevnar 7 vaccine, which protects against pneumonia and meningitis, has been shown to reduce the risk of recurrent pneumococcal infection in patients living with HIV in Malawai, according to a study published Thursday in the New England Journal of Medicine, Reuters reports.
Also In Global Health News: Maternal, Child Health In Rwanda, Pakistan, India; Mongolia Weather; H1N1
Rwanda Targets Communities In Effort To Curb Maternal Mortality To reduce maternal mortality in Rwanda and reach U.N. Millennium Development Goal targets, the government will conduct maternal death audits in villages to help identify ways to improve outcomes, Rwanda’s Minister of Health Richard Sezibera announced recently, the New Times/allAfrica.com reports.…
New Pneumonia, Meningitis Vaccine Approved In U.S.; Pfizer, GAVI Will Lower Price In Developing Countries
The FDA approved Prevnar 13 â€“ a “new version of a blockbuster vaccine that fights pneumonia, meningitis and other infections” â€“ for use in children up to age five in the U.S., Reuters reports (Richwine, 2/24).